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As “time is brain”, acute ischemic stroke is considered a medical emergency. With the 
introduction of thrombolytic therapy and availability of modern neuroimaging modalities, timely 
diagnosis of an ischemic lesion, exclusion of intracerebral hemorrhage, assessing the degree of 
brain injury, and evaluation of cerebral vasculature is necessary in acute stroke management. 
Various neuroimaging techniques have been used in selecting patients and guiding reperfusion 
therapies in patients with acute ischemic stroke during the initial hours of symptom onset. In this 
review we will highlight the importance of available imaging modalities used to assess patients 
with acute ischemic stroke.  
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Background 
 
Stroke is the fifth leading cause of death accounting for approximately one in every 20 deaths in 
the United States (1). It is also a major cause of severe long-term disability (2).
 
Stroke is 
classically characterized as an acute neurological deficit attributed to a vascular cause (3). Up to 
87% are ischemic with 10% being intracerebral hemorrhage (ICH) and 3% being subarachnoid 
hemorrhage (SAH) strokes (2). 
  
The aim of neuroimaging in acute stroke is to obtain rapid 
information on tissue and vessel status to aid acute stroke intervention.
 
   With the introduction of intravenous thrombolytic therapy and availability of modern 
neuroimaging modalities, timely diagnosis of an ischemic lesion and determining its vascular 
location and extent has led to efficient management of acute ischemic stroke and improved 
stroke outcomes (4-8).  
   The standard imaging modality used in the initial diagnosis of stroke is a non-contrast 
computed tomography (CT) scan of the head. This modality helps determine a hemorrhagic 
versus ischemic stroke (9). Magnetic resonance imaging (MRI) may eventually be substituted for 
CT as these become more readily available. MRIs can rapidly detect early ischemic lesions and 
the “ischemic penumbra” (10). One of the diagnostic advances with MRI is the diffusion-
weighted image (DWI) acquisition and apparent diffusion co-efficient (ADC) which allows early 
detection of an infarcted lesion (i.e., ischemic core) within minutes of a stroke (9).   
   In this review, we will highlight the various neuroimaging modalities currently available for 
diagnosing acute ischemic stroke and their utility in selecting patients for early reperfusion 
therapies, which has become a cornerstone of acute ischemic stroke intervention.  
 
Ischemic Penumbra 
 
Acute ischemic stroke is caused by an abrupt cessation of blood supply to the brain causing a 
decrease in cerebral blood flow (CBF). There exists a compensatory auto-regulatory mechanism 
in the brain parenchyma that maintains a constant cerebral blood flow during the initial periods 
of hypoperfusion (11). This autoregulation is via recruitment of collaterals and dilatation of 
smaller arterioles (11). This allows for maximal oxygen extraction by the hypoperfused tissues to 
maintain tissue oxygenation and cellular viability (11). However, when the CBF falls below a 
threshold of 20 to 23 mL/100 g tissue/min, neuronal function becomes impaired (11-14). Further 
drop in the CBF beyond this threshold leads to decrease in the cerebral perfusion pressure as the 
collaterals fail to provide tissue oxygenation, resulting in metabolic injury and tissue death (11-
14). The membrane channels ultimately fail causing a net shift of water into the cells resulting in 
cytotoxic edema and irreversible damage to the neuronal cells (11-14). This zone of irreversible 
cell injury is referred to as the “ischemic core”. It is surrounded by a zone of tissue at risk of 
infarction referred to as the “ischemic penumbra” (14-16). The penumbra is potentially 
salvageable and is the target of various reperfusion strategies in the management of acute 
ischemic stroke.  
   With the development of functional imaging modalities, such as CT perfusion (CTP) and 
DWI/perfusion weighted MRI, salvageable tissue can be identified for timely reperfusion therapy 
(17). 
 
Computed Tomography (CT) 
 
Due to its widespread immediate availability, CT remains the most common and the first line 
imaging modality used in acute ischemic stroke (18).  It is used to rule out hemorrhagic strokes 
(e.g., intracerebral hemorrhage (ICH)). By excluding ICH, patients presenting within the 
therapeutic window (3 to 4.5 hours from symptom onset) may be eligible for intravenous tissue 
plasminogen activator (tPA) (19).  
   CT may demonstrate subtle early signs of ischemia. An early finding on CT indicating cerebral 
ischemia is loss of gray-white matter differentiation (Figure 1), which occurs from the increasing 
water concentration from ion pump failure (i.e., cytotoxic edema) (20, 21). It may be detected in 
the region of basal ganglia (i.e., lenticular obscuration) or insular cortex (i.e., insular ribbon sign) 
(22, 23). However, the inter-rater agreement in recognizing these CT findings is variable (24-29). 
These findings are also time dependent. They appear in ≤67% in patients imaged within 3 hours 
but increase to 82% at 6 hours (24-29). To improve the detection rates and inter-rater reliability, 
the Alberta stroke program early CT score (ASPECTS) was developed to assess early ischemic 
changes (3 hours from stroke onset) in patients with acute ischemic stroke of the anterior 
circulation (30, 31). It is a simple rating scale which divides the affected middle cerebral artery 
into ten segments: internal capsule, caudate nucleus, lentiform nucleus, insula, and six segments 
for cortical areas. One point is deducted for each area showing early ischemic changes. A score 
of 10 reflects a normal CT scan. A score of 0 indicates diffuse ischemic involvement throughout 
the complete middle cerebral artery (MCA) territory (30).  
   CT head may also show evidence of a thrombus within an artery, seen as an increased density 
in the transverse M1 segment (i.e., hyperdense MCA sign) (Figure 2) or in cross-section within 
the Sylvian fissure or basilar artery (i.e., dot sign) (32). This indicates vessel occlusion with a 
high specificity but moderate sensitivity of 30-40% (33). The appearance of this early sign of 
acute ischemic stroke may be associated with worse prognosis and an increased risk of 
thrombolysis-associated hemorrhage (34). It is a predictor of early neurological deterioration 
with a positive predictive value of 91% (35, 36).   
   Ischemic strokes with hemorrhagic transformation are classified as either hemorrhagic 
infarction (HI) or parenchymal hematoma (PH). The hemorrhagic transformed strokes are then 
classified as HI1 (small petechiae), HI2 (more confluent petechiae), PH1 (<30% of infarcted area 
with some mild space-occupying effect), and PH2 (> 30% of the infarcted area with significant 
space-occupying effect) (37).  
 
Disadvantages:  
 
Although CT helps in excluding ICH, it cannot reliably differentiate between irreversibly 
damaged brain tissue (i.e., infarct core) and viable brain tissue (i.e., ischemic penumbra). Thus, it 
may be limited in selecting patients for various reperfusion therapies with an indeterminate time 
of symptom onset. It is also relatively insensitive in detecting acute and/or small cortical or 
subcortical infarctions, especially in the posterior fossa (38). 
 
                                        
 
 
Figure 1 (left). Axial computed tomography. Loss of gray-white matter differentiation in the left insular region is 
seen on the left (circle). Figure 2 (right). Axial computed tomography. Evolving stroke is seen in the right middle 
cerebral artery (MCA) territory (circle). Hyperdense MCA sign is seen on the right MCA (arrow).  
  
 
 
 
 
 
CT Angiography (CTA) and CT Perfusion (CTP) Imaging  
 
An important component of CT imaging protocol in the treatment of acute ischemic stroke is CT 
angiography (CTA), and at some centers CT perfusion (CTP) techniques. By allowing imaging 
of the intracranial vasculature, it can help identify the exact location and extent of vascular 
occlusion.  
 
CT Angiography (CTA) 
 
CTA is a relatively rapid technique making it ideal in acute stroke management. It is a thin-
section volumetric spiral (i.e., helical) technique following a time-optimized bolus of iodinated 
contrast medium to enhance visualization of the extra- and intra-cerebral circulations (39). The 
availability of new multidetector row CT technology and fast speed of acquisition of reformatted 
angiographic images has allowed visualization with high spatial resolution (39). It is useful in 
visualization of vessels from the aortic arch through the Circle of Willis within seconds (40). The 
sensitivity and specificity of CTA for the detection of intracranial occlusions is high ranging 92-
100% and 82-100%, respectively (41-44) (Figure 3). CTA is also sensitive and specific for 
imaging the extra-cranial vasculature as compared to carotid ultrasound in differentiating carotid 
occlusion from a very high grade stenosis (i.e., string sign) (45). 
 
Disadvantages: 
 
CTA requires the use of intravenous iodinated contrast medium, thus limiting its use in patients 
with contrast allergies and abnormal renal function.  
 
 
                                        
                                         
Figure 3. Axial computed tomography angiography (CTA). Occlusion of the right terminal internal carotid 
artery/proximal middle cerebral artery (MCA) is shown (arrow). Note the relative paucity of contrast filling vessels 
in the right MCA territory (circle) compared the left. This may indicate poor collateral circulation. 
CT Perfusion (CTP) 
 
CTP is a functional brain imaging modality which requires the administration of an intravenous 
bolus of an iodinated contrast agent. This technique allows perfusion imaging of the brain 
parenchyma and is useful in differentiating infarct from ischemic penumbra (46). CTP can 
reliably predict and identify ischemic penumbra and the irreversible ischemic core in patients 
with acute ischemic stroke within a few minutes on admission with a sensitivity and specificity 
of > 90% (47). This is achieved by measuring the following parameters: cerebral blood flow 
(CBF), cerebral blood volume (CBV), mean transit time (MTT), and time to peak (TTP) (Table 
1).  
 
 
Table 1. CT/MRI Perfusion Imaging Parameters in Acute Ischemic Infarct 
 
 Ischemic penumbra Infarct core 
MTT and TTP Increased Increased (threshold of 145%) 
CBV Normal to increased Decreased  
CBF Decreased (< 50% reduction) Decreased (> 60% reduction) 
MTT = mean transit time; TTP = time to peak. Cerebral blood volume (CBV) is the total volume of blood in a given 
unit of brain volume (normal = 4-5 mL/100 g). Cerebral blood flow (CBF) is the volume of blood moving through a 
given unit of brain volume per unit time (normal range in grey matter = 50-60 mL/100 g/min). Mean transit time 
(MTT) is the time difference between the arterial inflow and venous outflow (normal = 4 secs in grey matter). Time 
to Peak Enhancement (TTP) is the time from the beginning of contrast material injection to the maximum 
concentration of contrast material within a region of interest (ROI). The relationship between CBF and CBV is 
expressed by the equation CBF=CBV/MTT.  
 
 
   CBF is defined as the volume of blood flowing per 100g of brain mass per minute (48, 49). It is 
expressed as CBF=CBV/MTT (48, 49). Prolonged MTT together with CBF-CBV mismatch is 
the most sensitive measure in detecting the tissue at risk of infarction. A decrease in total CBV is 
the most specific indicator of the ischemic core (50, 51). Typically, in patients with acute 
ischemic stroke, CBF and CBV are low in the infarct core; whereas a decrease in CBF with a 
normal or increased CBV along with a prolonged MTT is seen in the ischemic penumbra (52, 
53) (Figure 4). 
   The ability of CTP to identify the penumbra makes it useful in treatment decisions in patients 
with indeterminate times of stroke onset or in cases of wake-up strokes (54). These patients may 
benefit from various reperfusion strategies. Figure 5 is an example of a right MCA occlusion 
seen on digital subtraction angiography (A) with recanalization of the superior division of the 
MCA (B). Any patient with a stroke (i.e., an acute neurological change within the past 24 hours) 
should be evaluated at a stroke center. At most stroke centers, a multimodal CT stroke protocol 
including CT head, CTP, and CTA is used. CTP imaging has the advantage of being performed 
during the same setting as CTA.  
 
Disadvantages: 
 
CTP requires repeated scanning of the same portion of the brain parenchyma until the contrast 
agent passes through the entire cerebral vasculature and produces a greater amount of radiation 
exposure. It also requires a multi-detector CT and a trained technician to set up the special 
software package and equipment. This limits its widespread availability. Use of a 2
nd
 bolus of 
iodinated contrast agent (after CTA) can predispose patients with renal insufficiency to contrast-
induced nephropathy.  
   CT, CTA, and CTP all have the disadvantage of radiation exposure.  
 
 
     
 
Figure 4. Computed tomography perfusion. A) Cerebral blood flow (CBF) showing decreased (circle) area of flow. 
B) Cerebral blood volume (CBV) showing area of decreased volume (solid circle) indicating core infarct with 
surrounding area of normal/increased CBV consistent with area of penumbra (dotted circle). C) Mean transit time 
(MTT) showing area of increased transit.  
 
 
 
               
 
Figure 5. Cerebral angiography. A) Acute occlusion of the right middle cerebral artery (MCA) is seen (arrow) with 
paucity of distal flow (circle). B) Restoration of flow in the superior division (arrow) after endovascular 
thrombectomy using stent retriever.  
  
A: CBF B: CBV C: MTT 
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Magnetic Resonance Imaging (MRI) 
 
Brain magnetic resonance imaging (MRI) imaging protocols for acute ischemic stroke include 
T1- and T2-weighted sequences, fluid attenuated inversion recovery (FLAIR) sequence, 
perfusion-weighted imaging (PWI), and DWI with corresponding ADC maps (46). These 
sequences can confirm the diagnosis of ischemia and guide the selection of patients for IV-tPA 
and other reperfusion strategies (46).  
   Conventional brain MRI sequences are not sensitive for detecting cytotoxic edema in the acute 
phase, whereas T1 and T2 weighted images can detect vasogenic edema and can help in 
differentiating acute versus subacute stroke (55-57). T2-weighted and FLAIR images can detect 
acute ischemic tissue within 3-8 hours after stroke onset, seen as hyperintense signals, with loss 
of grey-white matter differentiation and sulcal effacement similar to that seen with CT (55-57). 
FLAIR sequences are also useful in detecting subarachnoid hemorrhages (seen as bright signal) 
by suppressing the CSF signal (dark), as compared to T1 and T2 weighted images.  
   The gradient recalled echo (GRE) or susceptibility weighted image (SWI) sequences of MRI 
are more sensitive for detection of blood products and chronic hemorrhages, particularly chronic 
microbleeds, due to the paramagnetic effect of the hemosiderin. (58). These are seen as 
“blooming” effects and black on GRE images. They are used to assess the burden of underlying 
chronic vascular disease in stroke patients (59). 
   In comparison to T2 weighted and FLAIR sequences, DWI is the most sensitive (88-90%) and 
specific (95-100%) imaging technique for detecting acute ischemic change (60-64). Changes can 
be seen within a few minutes of symptom onset (60-64). Acquisition is based on the ability of 
diffusion weighted MRI to quantify motion of water molecules accumulated intracellularly in the 
injured neurons relative to extracellular space. This allows identification of ischemic cells on the 
DWI images which appear bright (46, 65). This should always be correlated with the ADC maps. 
Therefore, an increased signal on DWI (hyperintense) together with a decreased signal on ADC 
map represents an area of brain infarction (Figure 6). This sequence complement is known as 
restricted diffusion. DWI and ADC maps together with T2-weighted images and FLAIR 
sequences can be used to distinguish acute lesions from subacute or older infarcts (66, 67). In 
general, lesions appearing hypointense on ADC map are usually < 7-10 days old whereas lesions 
seen as isointense or hyperintense are more likely > 7-10 days old (66, 67). Lesions on DWI can 
also be used to identify stroke etiology. For example, isolated lenticulostriate lesion points to 
lacunar infarct whereas multiple lesions in different vascular territories suggest a cardioembolic 
source. Large artery atherosclerosis can manifest as scattered lesions within one vascular 
territory (6). 
 
Perfusion-Weighted Imaging (PWI) 
 
The combination of DWI and PWI is commonly used in clinical practice to evaluate the extent of 
irreversible tissue damage and to identify ischemic penumbra (68, 69). DWI along with ADC can 
identify tissue with permanent damage, whereas areas without signal change on DWI-ADC, but 
abnormal signal on PWI, represent salvageable tissue at risk (68,69). This area is the ischemic 
penumbra. A mismatch is considered significant if the penumbra is at least 20% of the ischemic 
core volume (70). The mismatch pattern is found in about 70% of all patients with anterior 
circulation stroke within 6 hours of onset, and may represent an indication for reperfusion 
treatment (69).   
                            
 
Figure 6. Magnetic resonance imaging (MRI) diffusion weighted imaging (DWI) and apparent diffusion coefficient 
(ADC). A) DWI showing area of hyperintensity in the right middle cerebral artery (MCA) distribution (circle). B) 
ADC showing hypointensity in the same MCA distribution (circle). The combination of DWI hyperintensity and 
ADC hypointensity is known as restricted diffusion.  
 
 
Magnetic resonance perfusion (MRP) parameters are similar to the ones seen on CTP (Table 1). 
However, these are more difficult to quantify as compared to CTP. Time to peak (TTP) and MTT 
are preferred for identifying hypoperfused tissue and cerebral brain perfusion; MTT and CBF 
denote ischemic penumbra and can predict the final infarct volume in absence of reperfusion (70, 
71).  In contrast to the CTP, there is availability of contrast-induced PWI technique which 
incorporates the use of gadolinium based contrast through the cerebral vasculature and measures 
various perfusion parameters but with lesser accuracy as compared to CTP.  
   MRP, as compared to CTP, has the advantage of imaging the entire brain parenchyma. MRP is 
more precise in predicting the tissue at risk and hence the final infarct volume and does not carry 
the hazard of radiation exposure or exposure to contrast agents as with CT perfusion protocol.  
 
MR Angiography (MRA) 
 
Magnetic resonance angiography (MRA) is a noninvasive technique used to evaluate extracranial 
and intracranial vessels and to identify the site of vascular occlusion or stenosis in patients with 
ischemic stroke (72). Several MRA techniques have been developed to image intra- and extra-
cerebral vessels. They include 2-dimensional time-of-flight (TOF), 3-dimensional TOF, multiple 
overlapping thin-slab acquisition (MOTSA), and contrast enhanced MRA (CE-MRA) (73).  
   Intracranial MRA has a sensitivity of 60-85% for stenosis and 80-90% for occlusions 
compared with CTA or digital subtraction angiography (DSA) (74). As compared to CTA, it can 
avoid the use of contrasted agents. In some cases, it overestimates the degree of vessel stenosis 
and motion artifacts as it is based on time of flight of blood flow.  
   Similarly, CE-MRA is more accurate with a greater sensitivity and specificity (95% and 90% 
respectively) than Doppler ultrasound for detecting extracranial vessel morphology, including 
carotid artery occlusions, stenosis, or dissections (75). As with MRI, it cannot be used in patients 
with pacemakers, metallic implants, and contraindications to MR contrast agents. Its use is 
limited in patients with severe claustrophobia. It also poses a significant risk of inducing 
A B 
nephrogenic interstitial fibrosis, secondary to use of gadolinium contrast agents in patients with 
renal dysfunction.  
 
Conclusion 
 
With the introduction of thrombolytic therapy in the treatment of acute ischemic stroke and a 
narrow therapeutic window (up to 4.5 hours from symptom onset in select patients), timely 
diagnosis is essential. CT imaging is required in the evaluation of acute stroke as it is quick and 
readily available. Several MRI modalities like DWI and ADC mapping are now being studied in 
the acute ischemic stroke diagnosis and management. Evaluation of cerebral vasculature in 
patients with ischemic stroke is important for endovascular therapy consideration. It is important 
to remember when considering an imaging modality that time is brain.  
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